The Growth of the Indian OrthoSpine Market

Old Diseases Frontier Markets

OrthoSpine diseases are not a new concept. Man has faced The Indian Healthcare market is forecast to grow by 15 % per annum to reach US $ 280 billion in 2020, with the OrthoSpine market constituting

problems of back pain, fracture, joint pain, shoulder disloca- 39% of the market share (figure 1). The Indian Spinal market is dominated by the Fusion systems (Figure 2) and the compound annual growth

tion, and arthritis from time immemorial. In ancient Greece, rate (CAGR) of the Spinal Interbody Device (IBD) market is expected to be 30.6 % per annum and is set to become a US $ 168 million industry by

the works of Hippocrates detail the treatment for spinal de- 2017 (Figure 3).

formities, spondylitis, dislocations of the shoulders, knees,

Ophthalmology Non fusion Systems 180

and hips, as well as treatments for infections resulting from 5% 5% 160

Revenue Trends (in US $) million)

compound fractures and spinal injuries. OrthoSpine has Woundcare 140

10 % Biologics 120

evolved with time and since World War II, treatments have 21 % 100

Cardiolgy 80
included spinal decompression therapy, joint replacements, 46%
Orthospine FusionSystems 60

arthroscopy, and a whole host of technologies. 39 % 74 % 40

20

0
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

Year
New Treatments Figure 1. Indian Healthcare Market Share Figure 2. Indian Spinal Market Share Figure 3. Indian Spinal IBD Market

Some of the technologies that are changing the way we treat

OrthoSpine diseases include the use of biologics, computer

A Pioneering Company
navigation systems and the rise in minimally invasive surger-
India is a rare example of a country in which both the population is growing and the living standards are improving. The demand for high
ies (MIS).
quality healthcare clearly exists but who will supply it? Allow Morulaa, with its strong pedigree and global contact network, to introduce you
Let it be the use of platelet rich plasma or bone morpho- to a market that demands supply like no other.
genetic protein, Biologics allow surgeons to modulate how

cells interact to enhance patients own healing response. FEASIBILITY SERVICES REGULATORY SERVICES DISTRIBUTOR SEARCH KOL MANAGEMENT
Individualized templates that are used to guide computer
Market entry, economic Maintain relationship with KOLs/
Registration and In- Country Distributor identification, con-
assisted surgeries and MIS procedures are taking OrthoSpine feasibility and business Physicians and attend trade
Representation of your product tract negotiation and continuous
development strategy for your shows on your behalf
in India monitoring of your distributor
treatments to new levels of efficiency and durability. MIS company

attracts patients due to the less surgical trauma associated

with them. Harshita Gupta, CEO | harshita@morulaa.com | +91 - 98402 61313 | www.morulaa.com |

Morulaa: Connecting Your Company With Its Future